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The commensal microbiota that inhabit different parts of the gastrointestinal (GI) tract have been shaped by
coevolution with the host species. The symbiotic relationship of the hundreds of microbial species with the
host requires a tuned response that prevents host damage, e.g., inflammation, while tolerating the presence
of the potentially beneficial microbes. Recent studies have begun to shed light on immunological processes
that participate in maintenance of homeostasis with themicrobiota and on how disturbance of host immunity
or the microbial ecosystem can result in disease-provoking dysbiosis. Our growing appreciation of this
delicate host-microbe relationship promises to influence our understanding of inflammatory diseases and
infection by microbial pathogens and to provide new therapeutic opportunities.Introduction
The mammalian gut harbors an enormous diversity of
commensal microbes that far outnumber the cells of the host.
The composition of the microbial community is thought to reflect
the coevolution of host and microbes to achieve a balanced,
mutually beneficial state. The microbiota contribute to host
nutrition and energy balance and to the development or mainte-
nance of a robust immune system. In turn, the host provides
a niche in which the individual microbes can persist within their
community, from which they may obtain essential nutrients,
ensuring their transmission and retention within the host
species. Although it has long been proposed that the microbiota
have important roles in a range of systemic diseases, only the
advent of new experimental tools, including gnotobiotic animals
colonized with defined commensal microbes, mouse inflamma-
tion models, and culture-independent approaches, particularly
massive parallel sequencing technology, has resulted in new
insights into how microbiota interact with the host immune
system. Recent studies have provided firm evidence that
skewing of the commensal community, often referred to as
‘‘dysbiosis,’’ can result in inflammatory diseases not only of the
intestine, but also of organs at distal sites. Such diseases can
be triggered not only by pathogenic microbes, but also by other-
wise harmless commensal microbes or those that are normally
held in check by the microbial ecosystem and/or the metabolic
state and immune response of the host. Thus, disturbance of
this homeostasis by intrinsic or extrinsic influences, e.g., treat-
ment with broad-spectrum antibiotics, can result in life-threat-
ening dysbiosis.
Deep sequencing of the fecal metagenome of healthy humans
has demonstrated remarkable interindividual variability of intes-
tinal microbial populations, but it has been suggested that
a limited number of balanced symbiotic states, referred to as
enterotypes, become established in the gut (Arumugam et al.,2011; Eckburg et al., 2005; Suau et al., 1999). Whether these
different enterotypes influence health and disease susceptibility
remains unclear. However, in light of recently described associ-
ations between specific intestinal commensal bacteria, T cell
differentiation, and inflammatory bowel disease (IBD), it seems
very likely that the complex constellation of commensal and
symbiotic bacteria in the gut influences the intestine’s innate
immune tone and modulates resistance to infection or suscepti-
bility to inflammatory disease. Thus, after nearly 150 years of
adhering to Koch’s postulates and investigating interactions
between specific bacterial pathogens and their human hosts,
microbiologists and immunologists now confront the more
complex challenge of dissecting the impact of a network of
nonpathogenic microbes on the mucosal immune system.
In this review, we will attempt to break down the variables that
contribute to homeostasis of microbiota and components of
host immunity. As will become apparent, it remains difficult
to make generalizations, as animal models reveal multiple
scenarios that result in inflammatory disease. What has become
clear, however, is that the combination of the host genotype and
the composition of the microbiota are the major determinants of
disease. The influence of the environment—e.g., diet, toxin, or
antibiotic exposure that can contribute to pathological inflamma-
tory conditions, perhaps triggering dysbiosis and/or a break-
down in epithelial barrier function—will also be discussed.
Components of the Intestinal Immune System
Organized Lymphoid Tissues
The mucosal tissues in the GI tract are considered to harbor
more cells of the immune system than all the secondary
lymphatic tissues combined. The composition and organization
of cells in the GI tract are still being defined, particularly with
the emergence of novel markers that allow further subdivision
of lineages or states of differentiation. In addition to the Peyer’sCell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc. 311
Figure 1. Schematic of Intestinal Immune System Cells Discussed
in This Review
Cryptopatches consist of RORgt+ lymphoid tissue inducer cells (that comprise
one of the subsets of ILCs) and dendritic cells (whose precise phenotype has
not been determined). Signals transmitted from microbiota to cryptopatches
result in influx of B lymphocytes to form isolated lymphoid follicles (not shown
in the figure). Induced Treg cells control the expansion and effector activity of
Th1 and Th17 cells as well as ILCs. TCRgd cells are not shown, but also
contribute to inflammatory cytokine production.
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lymphoid tissues that develop during fetal life, there are a series
of tertiary lymphoid tissue structures that develop postnatally,
which include isolated lymphoid follicles (ILFs) and crypto-
patches in the small intestine and colonic patches in the large
intestine (van de Pavert and Mebius, 2010). Development of all
such lymphoid tissues requires lymphotoxin-mediated signals
transmitted by innate lymphoid cells (ILCs) known as lymphoid
tissue inducer (LTi) cells. LTi cells and tertiary lymphoid tissues
are absent in mice deficient for the expression of the transcrip-
tion factors Id2 or RORgt. Cryptopatches consist of RORgt+
LTi cells surrounded by CD11c+ dendritic cells and underlie the
single cell layer of the intestinal epithelium (Figure 1). They
receive NOD1-dependent signals from the microbiota and
require signals mediated by the LTi cells for recruitment of B
lymphocytes and formation of ILFs (Bouskra et al., 2008; Tsuji
et al., 2008). ILFs are sites of mucosal secretory immunoglobulin
A (sIgA) production, which in the intestine occurs through both
T cell-dependent and -independent mechanisms and requires
microbial colonization (Macpherson et al., 2008).
Lymphoid Cells
In addition to the organized tissues, there are multiple other
immune cell subsets represented throughout the intestinal
lamina propria (LP) and the epithelium. These include a variety
of ILCs and myeloid cells as well as multiple types of T lympho-
cytes that express either the ab or the gd T cell antigen receptor
(TCR) and exhibit an activated or memory-like phenotype. The
LP is the site most enriched in differentiated ab CD4+ T cells,
particularly Th17 cells and regulatory T cells (Treg). Th17 cells
produce IL-17A, IL-17F, and IL-22, cytokines that have impor-
tant roles in clearing microbes that reach the LP and in maintain-
ing themucosal barrier, thus preventing inflammation induced by
microbial products that breach the epithelium. When not prop-
erly regulated, these cells can be potent mediators of inflamma-
tion. Treg cells, which express the transcription factor Foxp3 and312 Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc.often produce the anti-inflammatory cytokine IL-10, are most
prominent in the large intestine, the site of the highest concentra-
tion of microbiota. Many of the Foxp3+ cells acquire their regula-
tory phenotype in the LP microenvironment and are designated
induced regulatory T cells (iTreg) to distinguish them from cells
that acquire Foxp3 during thymic development (designated
natural, or nTreg) (Curotto de Lafaille and Lafaille, 2009).
ILCs include several phenotypic variants that mirror T helper
cells in their cytokine profiles. Cells that express very high levels
of IL-22 and/or lower levels of IL-17 make up a large fraction
of ILCs, and like Th17 cells, they are distinguished by the
expression of the transcription factor RORgt and by IL-23R
and the chemokine receptor CCR6. LTi cells fall in this category,
although it is unclear if they can be classified based on a distinct
phenotype. IL-23 produced by myeloid cells is required for the
differentiation of LTi cells, particularly for their expression of
IL-22, and the interaction of LTi expressed CCR6 with its ligand,
CCL20, is thought to be critical for their localization. IFNg-
producing NK cells and recently described lymphoid cells that
produce IL-4 or IL-13 are also present in the intestinal LP and
can bemodulated in the presence of diversemicrobes (reviewed
in Spits and Di Santo, 2011).
Myeloid Cells
Among myeloid cells, CD103+ DC and CD103CX3CR1
hi DC
(also designated as macrophages because they are thought to
be nonmigratory) have received the most attention, in part
because the former were shown to be endowed with the enzy-
matic machinery to produce retinoic acid, which enhances the
conversion of CD4+ T cells to the iTreg phenotype. The myeloid
cells, particularly the monocyte-derived cells that express high
levels of the fractalkine receptor CX3CR1, extend processes
through the tight junctions of intestinal epithelial cells and
make contact with lumenal contents (Figure 1). Extension of
dendrites is dependent on signals from lumenal commensal
bacteria by way of the Toll-like receptor (TLR) adaptor MyD88
in epithelial cells (Chieppa et al., 2006) and on expression of
CX3CR1 and its ligand (Niess et al., 2005). Sampling of lumenal
contents by a CX3CR1-dependent mechanism has been
reported as important for immunological tolerance to orally
ingested antigen, but a role for this process in immune responses
to microbial products has not yet been established (Hadis et al.,
2011).
Influence of the Microbiota on the Intestinal
Immune System
Colonization of the intestinal tract with diverse microbes has
a profound influence on the development and function of both
innate and adaptive branches of the immune system. In antibi-
otic-treated mice, the reduction in MyD88-mediated innate
immune signals induced by bacterial products renders the
mucosa more permeable to commensal bacteria and less
capable of postinjury repair (Vaishnava et al., 2008). Induction
of TLR signaling, e.g., by supplying LPS, can substitute for gut
bacteria in protecting the epithelium from potential damage
(Rakoff-Nahoum et al., 2004). Defects in various other innate
immunity signaling modules, e.g., NOD2 or components of
inflammasome signaling pathways involved in release of IL-1b
and IL-18, can result in increased risk for IBD or in uncontrolled
growth of invasive enteropathic bacteria in humans and in
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do not discriminate between molecular components of normally
harmless commensals and pathogenic invasive bacteria. How
the host immune system selectively clears pathogens while
tolerating the presence of commensals remains one of the key
unanswered questions in microbe-host mutualism. One possi-
bility is that commensals, by virtue of being noninvasive, do
not gain access to immune system cells with innate receptors.
However, as discussed below, there is now ample evidence
that commensal bacteria do indeed influence the differentiation
state of immune system cells in the intestinal LP. Moreover,
innate signaling receptors, e.g., various TLRs, are present on
the surface of epithelial cells, albeit not always at the apical
surface or readily accessible through the mucus layer that is
rarely penetrated by commensals. An alternative possibility,
which we favor, is that coevolution of host and commensal
microbial communities has led to a mutualistic de´tente that
provides a means of avoiding inflammation while preventing
elimination of key microbial constituents through the activation
of innate and adaptive immune components. This homeostasis
is likely also promoted by microbe-induced Tregs that restrain
potential inflammatory responses by both adaptive and innate
arms of the immune system. In this setting, a disturbance of
homeostasis can result in aberrant activation of the largely
promiscuous innate receptors, in subsequent tissue damage,
and potentially in systemic inflammation. A major shift in the
composition of the commensal community can also result in
outgrowth of invasive pathogenic microbes, as illustrated by
infections following treatment with antibiotics and discussed in
detail below.
Effector T Cell Responses
The proportion of Th17 and iTreg cells differs according to the
site in the gut (e.g., small versus large intestine) and the compo-
sition of themicrobiota. The latter varieswidely between different
institutional animal facilities, and this factor needs to be consid-
ered when interpreting results reported for various models of
inflammation. Mice lacking expression of TCRa develop a spon-
taneous colitis that is dependent on the presence of commensal
microbiota (Bhan et al., 1999). This was an early observation that
suggested a loss of regulation of inflammatory processes in the
absence of ab T cells. Mutations resulting in loss of IL-2 or its
receptor subunits similarly resulted in microbiota-dependent
spontaneous colitis, which can now be ascribed to the absence
of Treg cells in these mice (Sadlack et al., 1993). Adoptive trans-
fer of naive T cells into B and T cell-deficient mice results in colitis
only if mice are colonized with intestinal microbiota, which
contribute to the expansion of effector T cells in the absence
of Treg cells in the LP (Maloy and Powrie, 2011). Colitis in this
commonly used T cell transfer model requires expression in
the transferred cells of RORgt and the receptor for IL-23, which
are both essential for the differentiation of Th17 cells. IFNg-
producing Th1 cells also have a prominent role in this and related
models of colitis, but Th17 cells are essential for disease patho-
genesis, and fate-mapping studies have shown that Th1 cells in
inflammatory settings can be derived from IL-17A-expressing
precursors (Hirota et al., 2011).
Microbial communities, which include hundreds of bacterial
species as well as fungi and viruses that have received consider-
ably less attention, influence the abundance of ab and gd T cellsand the production of sIgA by plasma cells in the intestinal
mucosa. Much recent attention has focused on how the micro-
biota govern the balance of CD4+ T cell subsets in the intestinal
LP. Our current understanding of how this is achieved is limited
to a handful of individual bacterial species that can direct the
accumulation of either Th17 cells or Treg cells in the LP of small
and large intestine. Gnotobiotic mice, which lack the microbial
flora, have no Th17 cells in either small or large intestine. Coloni-
zation of such germ-free mice with the Gram-positive anaerobe
segmented filamentous bacterium (SFB) results in accumulation
of Th17 cells, primarily in the small intestine, where SFB asso-
ciate closely with the intestinal epithelial cells (Gaboriau-
Routhiau et al., 2009; Ivanov et al., 2009). SFB influence the
balance of intestinal CD4+ T cells not only in monoassociated
mice, but also in mice that harbor a diverse microbiota. For
example, C57BL/6 mice with a diverse microbiota but lacking
SFB have few intestinal Th17 cells, but they have at least five
times as many Th17 cells after they are colonized with SFB or
exposed to feces from mice that have SFB in their commensal
community (Ivanov et al., 2008). SFB represent only one of
what is likely to be a large number of microbes that elicit Th17
cells. A variety of bacteria generally considered pathogenic,
e.g., Citrobacter rodentium, Klebsiella pneumoniae (Happel
et al., 2005), and Salmonella typhimurium (Godinez et al., 2008,
2009; Schulz et al., 2008), as well as fungi, e.g.,Candida albicans
(Conti et al., 2009), induce Th17 cells in the intestine or at other
mucosal surfaces. The cytokines produced by the Th17 cells
are essential for protecting the mucosal barrier from these path-
ogenic microbes. In accord with this, colonization of mice with
SFB provides protection from subsequent colonization with
C. rodentium. Although the protection can be ascribed, at least
in part, to induction of Th17 cells, it cannot be ruled out that
SFB have additional beneficial properties that limit access of
pathogenic bacteria to the mucosal epithelium. For example,
short-chain fatty acids produced by commensal bacteria
provide substantial intestinal barrier protection (Maslowski
et al., 2009), and SFB may similarly employ this metabolite to
reduce colonization with pathogenic bacteria.
Polarization of antigen-stimulated T cells toward the Th17
profile requires the presence in the microenvironment of IL-1b,
IL-6, IL-23, and TGF-b. Fungi produce b-glucans, whose interac-
tion with Dectin-1 selectively induces production of IL-23 by
dendritic cells (Reid et al., 2009). Pathogenic bacteria presum-
ably gain access to the epithelium and penetrate it, activating
multiple innate sensors, including TLRs and NLRs, resulting in
production of the Th17-inducing cytokines. How SFB or other
commensals promote Th17 cell differentiation is less clear.
SFB have the unique property of adhering closely to intestinal
epithelial cells, particularly in the terminal ileum. To do so, SFB
must penetrate the thick layer of mucus that overlays the
epithelium. Study of the biology of SFB has been hampered by
the inability thus far to culture this spore-forming anaerobe.
However, the recent elucidation of the SFB genomic sequence
promises to provide new tools to elucidate its mechanism of
action (Kuwahara et al., 2011; Prakash et al., 2011; Sczesnak
et al., 2011). For example, SFB encode multiple glycan foraging
enzymes, which may facilitate their ability to penetrate mucin,
and several flagellins, among which at least three can activate
TLR5. Whether TLR signaling is involved in SFB-induced Th17Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc. 313
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cells by transfer of SFB-containing microbiota into SFB-deficient
mice does not require MyD88 or TLR3 and hence appears to be
independent of TLR engagement (Ivanov et al., 2008). The ability
of SFB to gain close access to the epithelium and, potentially, to
processes extended by dendritic cells may underlie their
capacity to induce Th17 cell differentiation, but characterization
of the signaling pathways involved awaits further investigation.
Induction of Th17 cytokines requires ligation of the TCR, but
the specificity of LP Th17 cells does not appear to be restricted
to microbial antigen. Mice with monospecific T cells have intes-
tinal Th17 cells and monoassociation of mice with SFB results in
as many Th17 cells as in mice with a broad spectrum of intestinal
microbes (Ivanov et al., 2009; Lochner et al., 2011). Th17 cells
may therefore be in large part self-reactive T cells circulating
through the LP, where a reduced threshold for TCR signaling
and the presence of appropriate cytokines results in their polar-
ization. Such T cells may then circulate out of the intestine and
would be available for recruitment to other sites in the body,
where inappropriate activation can result in organ-specific
Th17 cell-mediated autoimmunity (Lee et al., 2011; Wu et al.,
2010; Mathis and Benoist, 2011).
A large fraction of gd T cells in the LP also express the cyto-
kines associated with Th17 cells. Unlike ab T cells, gd T cells
are induced to produce effector cytokines by IL-23 and IL-1b
even in the absence of TCR ligation (Sutton et al., 2009). In this
manner, they resemble ILCs and are thought to provide early
protection against pathogenic microbes (Jensen et al., 2008).
The number of gd T cells has not been shown to be affected
by commensal microbiota, although intraepithelial lymphocytes
(IELs) bearing the ab TCR do expand upon colonization of
germ-free mice with SFB (Umesaki et al., 1995). IELs may
provide a critical link between the microbiota and innate intes-
tinal responses, as the transcriptional program of gd IEL is regu-
lated by commensals and their ablation increases gut perme-
ability to commensals following injury (Ismail et al., 2011).
ILCs in Inflammation
There has been considerable recent interest in the functions of
ILCs that are particularly abundant in the intestinal LP. Intestinal
ILCs that produce IL-17 and/or IL-22 are dependent on RORgt
for their differentiation and appear to participate in a variety of
inflammatory processes. In a mouse model of innate immune
system-mediated IBD, elicited by colonization of RAG-deficient
mice with Helicobacter hepaticus, IL-23R and RORgt were
required for the development of Thy-1+CD127+ ILCs that medi-
ated the disease through production of IL-17 and IFNg (Buono-
core et al., 2010). Polymorphisms in IL-23R are strongly associ-
ated with incidence of Crohn’s disease, consistent with the
importance of these effector cells along with T cells in the path-
ogenesis of IBD in humans. Similar to effector T lymphocytes, the
inflammatory function of ILCs is also subject to suppression by
Treg cells.
In contrast to the proinflammatory function of ILCs revealed in
the innate IBD model, a protective function of ILCs was demon-
strated in response to infection with enteropathic C. rodentium.
Following infection, IL-22 production was far higher in ILCs than
in T cells. IL-22, which regulates expression of antimicrobial
peptides by intestinal epithelial cells, is essential in protecting
the host from infection with C. rodentium (Zheng et al., 2008).314 Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc.Production of IL-22 by the ILCs was dependent on the presence
of IL-23 and was sufficient to protect RAG-deficient mice from
lethal infection. Mice reconstituted with T cells and depleted of
ILCs with anti-isotype antibody succumbed to infection, sug-
gesting that ILCs are more critical than T cells for barrier protec-
tion in this model (Sonnenberg et al., 2011). A role for microbiota
in the accumulation of mucosal ILCs has been suggested, but
results have not been consistent, and it is also unclear if there
are discrete effects on specific subsets of ILCs. Colonization of
mice with SFB resulted in increased LP Th17 cells, but no
obvious change in ILCs (Ivanov et al., 2009). Because SFB
reduced the amount of C. rodentium associated with colonic
epithelium, it will be important to investigate beneficial functions
of SFB that are independent of Th17 cell induction.
Treg Cells and the Microbiota
Recent studies indicate that Treg cells are also regulated by the
microbiota. In conventional animal facilities, representation of
Treg cells among CD4+ T cells is much higher in the large intes-
tine and, to a lesser degree, in the small intestine than in lymph
nodes or other secondary lymphoid organs. Removal of micro-
bial flora results in an increased fraction of Treg cells in the small
intestine, although there are fewer total CD4+ T cells and Th17
cells are absent. In the large intestine, in contrast, there is
a substantial reduction in Treg cell numbers in germ-free mice.
This reduction is largely in the iTreg population, which is defined
by the absence of expression of the transcription factor Helios.
The iTreg cells were largely restored by colonization of germ-
free mice with a mixture of 46 Clostridial strains, enriched in
representation of clusters IV and XIVa (Atarashi et al., 2011).
Colonization with the mixed Clostridia was also sufficient to
induce IL-10, an anti-inflammatory cytokine, and CTLA4, amole-
cule that inhibits T cell activation, in a substantial fraction of the
iTreg cells. When neonates kept in a conventional specific path-
ogen-free facility were gavaged with the Clostridia, the animals
were protected from inflammation induced with disodium sulfate
(DSS) or oxazalone and displayed lower levels of ovalbumin-
induced IgE. Moreover, Clostridia elevated the proportion of
Treg cells not only in the gut LP, but also in other organs,
including lung, liver, and skin.
Properties of Clostridia that contribute to induction of iTreg
cells and the specificity of the iTreg cells in this setting are not
yet known. However, a notable recent study has shown that
iTreg cells have a unique TCR repertoire that confers specificity
for commensal bacteria, and other results suggest that bacterial
products can influence the Th17:Treg balance, potentially by
favoring iTreg cell differentiation or expansion. The specificity
of LP T cells was addressed recently by Lathrop et al. (Lathrop
et al., 2011), who showed that intestinal iTreg cells have a TCR
repertoire distinct from that of naive and effector LP CD4+
T cells. TCRs of most iTreg cells were found to recognize anti-
gens present in the heat-killed lumenal content from mice
colonized with commensal microbiota, but not from germ-free
mice, and some of the TCRs were reactive with single bacterial
species. When the TCRs of microbiota-reactive Treg cells
were introduced into naive T cells, those newly activated cells
expanded and became colitogenic upon transfer into RAG-
deficient mice. These results suggest that exposure of naive
T cells to antigens derived from intestinal microbiota induces
the differentiation and expansion of iTreg cells rather than
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vidual bacterial species. Because these experiments focused
on restricted pairs of TCRa and b chains, it remains unclear
whether other combinations of TCRs may bias differentiation
toward effector T cells. How exposure to microbial antigen
favors iTreg cell differentiation versus expansion of effector
cells or polarization to a particular effector phenotype (e.g.,
Th17 cells) is an important question for future investigation.
The answer may be found in microbial products that induce
production of distinct cytokines by cells in the microenvironment
or even by the T cells themselves. Thus, polysaccharide A (PSA)
produced by Bacteroides fragilis, a commensal bacterium of
humans, protects mice from colitis induced upon colonization
with Helicobacter hepaticus (Mazmanian et al., 2008). The
mechanism of protection has been proposed to involve TLR2-
dependent induction in T cells of IL-10, which restrains proin-
flammatory Th17 cells (Round et al., 2011). In contrast to the
Clostridia, PSA+ B. fragilis had only a modest influence on the
proportion of intestinal Treg cells, and it is not known if PSA influ-
ences iTreg cell abundance in vivo. Nevertheless, it is likely that
there are multiple commensal bacteria that have the capacity to
influence the differentiation of iTreg cells, potentially through
regulating the levels of TGF-b, retinoic acid, and IL-2, which
contribute to iTreg cell differentiation. The molecular mecha-
nisms by which bacterial products affect release of these and
other mediators will no doubt be the subject of intense investiga-
tion. Together, the recent results raise the exciting possibility that
specific commensals or their products may be therapeutically
beneficial in a variety of systemic or organ-specific autoimmune
diseases.
Inflammatory Bowel Disease and Dysbiosis: Lessons
from Experimental Models
A series of recent reports have highlighted the importance of
a balanced intestinal microbiota for maintenance of a healthy
mucosal barrier. Some of the experiments were prompted by
the results of genome-wide association studies (GWAS) aimed
at detecting polymorphisms associated with IBDs in humans,
while others were based on examination of mice with mutations
in key genes involved in adaptive and innate immune responses.
Animal models based on GWAS results have shed light on the
importance of innate signals and an intact autophagy machinery
in barrier function, particularly when challenged by viral infection,
but there has been only limited analysis of the effects of auto-
phagy on the microbiota (Cadwell et al., 2010). Mice with muta-
tions in many of the genes involved in innate sensing have been
examined in various models of IBD, and the role of the intestinal
microbiota in such mice is generating much interest. A notable
recent study described the consequence of impaired inflamma-
some signaling on sensitivity of the intestinal mucosa to mild
chemical disruption with DSS (Elinav et al., 2011). Inactivation
of NLRP6, resulting in reduced IL-18 production, rendered
mice highly susceptible to DSS colitis. Remarkably, cohoused
wild-type mice became similarly susceptible, and this was
ascribed to sharing of a dysbiotic microbiota by mice within
the colony. The mutant mice displayed a shift in the fecal micro-
biota, and this bias was transmitted to cohoused animals. There
was a marked increase of a novel member of the Prevotellaceae
family, in the phylum Bacteroidetes, and of a member of thephylum TM7, and antibiotics that reduced association of these
bacteria with colonic crypts suppressed the DSS colitis pheno-
type. Spontaneous colonic inflammation and elevated produc-
tion by the epithelium of the chemokine CCL5 were observed
in both mutant and cohoused wild-type mice, and DSS-induced
disease was dependent on CCL5. This is thus an example of
a dominant effect of commensal dysbiosis, with apparently
asymptomatic inflammation in the setting of an undisturbed
gut epithelium. It is conceivable that similarly biased microbial
communities exist in humans and contribute to disease only if
the mucosal barrier is perturbed, e.g., by toxins or diet. It should
be noted that a direct role has not been demonstrated for the
bacterial species that prevail in this model, and their expansion
may be secondary to the host response to other constituents
of the microbiota. Colonization of mice with individual cultured
bacterial species will be needed to demonstrate a direct role of
such bacteria in colitis. The effector mechanism in this disease
model is also yet to be elucidated, and it is thus unclear if
T cell function is disrupted, e.g., Th1 cell differentiation in the
setting of reduced IL-18. It will also be of great interest to learn
the nature of the NLRP6 ligand that contributes to healthy
homeostasis.
Another example of dysbiosis in the setting of a compromised
immune system was described in mice defective for both IL-10
and TGF-b receptor signaling (Bloom et al., 2011). These
signaling pathways were implicated by GWAS in human IBD.
Mice deficient in IL-10R2 and expressing a dominant-negative
TGF-bR2 in T cells developed spontaneous colitis with high
penetrance, but disease was prevented by administering
metronidazole and ciprofloxacin, antibiotics typically employed
in treatment of ulcerative colitis. By gavaging mutant mice
after neonatal antibiotic treatment with commensal anaerobes
grown in different selective media, it was demonstrated that
commensal Bacteroides, specifically B. thetaiotaomicron and
B. vulgatus, were sufficient to induce colitis. Unlike the previously
described model, wild-type mice cohoused with the mutant
animals or gavaged with the same Bacteroides species were
resistant to disease. In addition, there was no enrichment of
the Bacteroides in mutant versus wild-type mice, although there
was enrichment of commensal Enterobacteriaceae, such as
E. coli, that did not transmit disease. The effector mechanisms
mediating colitis are not yet known, but there was an increase
in Th1 cells, as expected in the absence of Treg cells (which
require TGF-b signaling for differentiation and/or survival) and
of IL-10- and TGF-b-mediated inhibition of IFNg expression.
Whether IFNg and/or ILC functions are required for the effector
phase of disease will await further studies. This model thus
represents a second category of dysbiosis associated with
immune dysfunction, in which disruption of a host immune
homeostatic process uncovers an inflammatory signal initiated
by a defined bacterial species. Unlike the inflammation initiated
in the absence of NLRP6 signaling, the microbiota in this case
did not appear to have any pathogenic effect in wild-type
mice, and it is even unclear if there was indeed dysbiosis that
contributed to disease, rather than a loss of host regulatory
signaling.
A related model of IBD was described in TRUC mice, which
are defective for the transcription factor T-bet and lack an adap-
tive immune system due to RAG2 deficiency (Garrett et al.,Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc. 315
Figure 2. Examples of How Commensal or Pathogenic Microbiota
Can Influence Immune Homeostasis in the Gut
SFB and various clostridia can induce accumulation of Th17 or iTreg,
respectively. Commensal bacteria like Prevotella do not associate with the
epithelium unless there is dysbiosis, as observed in mice with mutations in
NLRP6 or IL18. Such bacteria may elicit antigen-specific iTreg cells,
preserving immune tolerance to the microbiota. It is hypothesized that
displacement of the bacteria to the epithelial surface results in inflammatory
signals and changes in the epithelial permeability. Invasive bacteria like
Klebsiella orCitrobacter are typically held in check by the host immune system,
but can breach the epithelium when pathways related to Th17 cells or ILCs are
compromised.
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and mutant offspring had significantly different commensal
communities compared to wild-type siblings. Disease in this
model was due to elevated production of TNF-a by T-bet-defi-
cient dendritic cells and was prevented by antibiotic treatment
or blockade of TNF-a as well as by adoptive transfer of Treg
cells. The TRUC colitis was communicable to T-bet-sufficient
mice and was more severe in RAG2-deficient mice than in
wild-type mice, likely due to absence of Treg cells in the former.
The TRUC mice, but not RAG2-deficient mice, had culturable
K. pneumoniae and Proteus mirabilis in their feces, and transfer
of these bacteria to RAG2-deficient mice induced the colitis
phenotype. However, germ-free TRUC mice were resistant to
disease induction with these bacteria, indicating that an endog-
enous microbial community was additionally required for colitis
to develop. The K. pneumoniae and P. mirabilis were found to
penetrate the mucus layer of the colon and to be closely
associated with the apical surface of the epithelial cells (Garrett
et al., 2010). The mechanism by which they contribute to inflam-
mation is unclear, but it likely involves either direct interactions of
microbial products with cells at the epithelial surface or indirect
effects conveyed through host immune cells sensing the mislo-
calized bacteria. This example of a transmissible dysbiosis
may also apply to human IBD, but unlike that observed with
NLRP6-deficient mice, this disease scenario involves what are
commonly thought of as pathogenic bacteria.
The microbiota-dependent inflammation described in the
three examples above occurs in the setting of diverse genetic
defects in innate and adaptive immune functions and may be
horizontally transmissible under special circumstances (Fig-
ure 2). Pre-existing immunological impairment may not be a316 Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc.prerequisite for dysbiosis-mediated inflammation, however.
Treatment with antibiotics may shift the microbiota, allowing
for outgrowth of invasive pathogenic bacteria, e.g., vancomy-
cin-resistant enterococci or Clostridium difficile, as described
below. It cannot be ruled out that exposure to certain antibiotics,
diet, or environmental toxins can also favor dysbiosis in which
normally harmless commensals can trigger inflammatory pro-
cesses. Although such examples have not yet been reported
in experimental models, the apparent proinflammatory activity
of Prevotella-enriched microbiota in the mucosa of wild-type
animals in the Elinav et al. (2011) study discussed above
suggests that alterations in the representation of individual
commensal constituents may result in disease induction. For
example, a community that achieves a stable bias favoring
inducers of effector cells (e.g., Th1, Th17, ILCs) over inducers
of Treg cells may result in perpetuation of an inflammatory state.
The term ‘‘pathobiont’’ has been coined to describe commensal
bacteria that can be pathogenic in such a setting (Round and
Mazmanian, 2009). While single commensal micro-organisms
that induce disease may exist, it will be necessary to consider
the impact of the broader community of microbiota in potentia-
tion of disease. Accumulating data from metagenomic analyses
of microbiota present at different stages of inflammatory
diseases will likely provide critical insight into how microbial
communities participate in such diseases.
Antibiotic Effects on the Intestinal Microbiota
and Immune Defense
While colonization of germ-free mice with specific commensal
organisms has been informative, this approach can be limited
by the dependence of different commensal microbes upon their
fellow commensals. An alternative approach to characterizing
the impact of commensal bacteria on mucosal immunity is to
alter themicrobiota by antibiotic administration. Antibiotics differ
in terms of antimicrobial spectrum, tissue localization, and
excretion, properties that can be also affected by the route
of administration. Some intravenously administered antibiotics
are excreted by the kidneys and do not achieve significant levels
in the GI tract, while other antibiotics are concentrated by the
liver in the bile and are excreted into the intestinal lumen.
Short-term administration of Clindamycin, an antibiotic that is
concentrated in bile and thus achieves high levels in the intes-
tine, dramatically alters the microbial composition of the human
colon for up to 2 years (Jernberg et al., 2007), while systemic
administration of vancomycin, which is cleared by the kidneys,
leaves the intestinal microbiota intact. Current understanding
of the effect of specific antibiotics on short- and long-term
colonization with diverse bacteria is limited. Administration of
ciprofloxacin, a commonly used antibiotic with little activity
against obligate anaerobic bacteria, altered the abundance of
roughly one-third of intestinal bacteria in three healthy volun-
teers, with a significant loss of microbial diversity during treat-
ment (Dethlefsen et al., 2008). Although the diversity of the
microbiota returned within weeks of antibiotic cessation, there
were long-term losses of some bacterial taxa that persisted for
6 months (Dethlefsen et al., 2008).
Most studies of the human gut microbiota have focused on
fecal samples, largely because access to the small intestine is
technically and anatomically challenging. Studies in mice,
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the small intestine and the colon are distinct, with markedly
different responses to antibiotic administration. Treatment of
mice with ampicillin/metronidazole/bismuth or with cefopera-
zone revealed dramatic effects on the intestinal microbiota and
also showed that mice quickly share intestinal flora as a result
of coprophagia (Antonopoulos et al., 2009). Cohousing antibi-
otic-treatedmice with untreatedmice results in the rapid normal-
ization of the microbial flora. Oral streptomycin or vancomycin
alters the flora of the murine cecum and colon and results in
the expansion of g-proteobacteria populations (Sekirov et al.,
2008). Antibiotic treatment also impacts T cell populations in
the colonic LP, with decreased IFNg and IL17A production (Hill
et al., 2010). Treatment of mice with oral vancomycin or ampi-
cillin markedly reduced bacterial density in the ileum and cecum
(Ubeda et al., 2010). Mice treated with oral vancomycin often
became heavily colonized with bacteria belonging to the Entero-
bacteriaceae family, perhaps because this antibiotic has limited
activity against Gram-negative bacteria. Treatment with ampi-
cillin, on the other hand, did not result in expansion of Enterobac-
teriaceae. Upon cessation of antibiotic treatment, bacterial
density rapidly returned to pretreatment levels, but the microbial
composition remained altered (Ubeda et al., 2010).
An interesting aspect of postantibiotic rebound microbial
expansion is its variability between similarly treated mice.
Thus, when separately housed mice with similar microbial flora
were treated with the same antibiotic regimen, there were
blooms and crashes of gut bacterial populations, resulting in
vastly different patterns at 2–3weeks after cessation of antibiotic
treatment (Ubeda et al., 2010). The consequences of these
differences in the microbiota for susceptibility to infection and
immune defense remain unclear. Recent studies of the fecal
metabolome have demonstrated that broad-spectrum antibiotic
administration affects the levels of 87% of detectable host mole-
cules, including steroid hormones, eicosanoids, and bile acids
(Antunes and Finlay, 2011; Antunes et al., 2011). It is reasonable
to speculate that the marked and currently unpredictable fluctu-
ations in the intestinal microbiota that follow antibiotic treatment
result in equally unpredictable effects on immune defenses.
As discussed above, intestinal microbes and their products
stimulate innate immune receptors and drive expression of anti-
microbial factors by intestinal epithelial cells. For example,
Nod2-mediated signals drive the expression of some cryptdins,
thereby enhancing resistance to intestinal invasion by Listeria
monocytogenes (Kobayashi et al., 2005) and limiting the density
of commensal bacteria in the ileum (Petnicki-Ocwieja et al.,
2009). Commensal bacteria also induce the expression of
RegIIIg, a secreted C-type lectin that kills Gram-positive bacteria
(Cash et al., 2006). Expression of RegIIIg is dependent on TLR
signaling (Brandl et al., 2007), and MyD88-deficient mice,
despite colonization by commensal bacteria, do not express
RegIIIg. TLR-mediated signaling can occur in cells that are not
of hematopoietic origin, and MyD88 expression in Paneth cells
is sufficient to drive RegIIIg expression (Vaishnava et al., 2008).
Antibiotic administration to mice greatly reduces RegIIIg expres-
sion and rendersmice susceptible to colonization with antibiotic-
resistant bacteria such as vancomycin-resistant Enterococcus
faecium (VRE) and Clostridium difficile (Jarchum et al., 2011;
Kinnebrew et al., 2010). Orally administered LPS stimulatesRegIIIg expression in the ileum of mice that have been treated
with broad-spectrum antibiotics. In this setting, LPS-induced
RegIIIg expression results from MyD88-mediated signaling in
nonhematopoietic, presumably epithelial cells, and thus simu-
lates commensal-driven RegIIIg induction (Brandl et al., 2008).
In contrast to commensal or oral LPS-driven RegIIIg expression,
systemic flagellin administration drives RegIIIg expression that is
dependent on TLR-5 or MyD88 expression in cells of hematopoi-
etic origin (Kinnebrew et al., 2010). Systemic flagellin administra-
tion also corrects the loss in mucosal innate immune defenses
in the ileum and protects against colonization of mice with VRE
or lethal infection with Clostridium difficile. Flagellin-induced
RegIIIg expression is highly dependent on IL-22 production,
although the flagellin-responsive and IL-22-producing cells
remain to be identified (Kinnebrew et al., 2010).
Interaction between Microbiota and Intestinal
Pathogens
Bona fide intestinal bacterial pathogens cause disease in
humans in the absence of known immunodeficiency or defects
in the host’s intestinal microbiota. Thus, organisms such as
Shigella flexneri, enteroinvasive Escherichia coli, Salmonella
enterica, and Vibrio cholera cause dysentery or profuse diarrhea
upon oral ingestion by otherwise healthy individuals. Experi-
mental studies in humans demonstrated that the inoculum of
bacteria required for successful infection varies markedly for
these pathogens. Shigella flexneri is the most infectious and
causes disease in some individuals following ingestion of as
few as 100 live bacteria (DuPont et al., 1989). However, while
100 live bacteria caused infection in 39% of volunteers,
increasing the dosage to 105–108 only increased the rate of
infection to 64%. Thus, although not previously exposed to
Shigella, 36% of volunteers remained resistant to inoculation
with very high doses of this pathogen (DuPont et al., 1989). In
contrast to Shigella infections, successful infection, defined as
prolonged high fever and diarrhea, required much higher doses
of viable Salmonella typhi, Escherichia coli, or Vibrio cholera.
Challenge of human volunteers with 103 live Salmonella typhi
did not cause infection, and oral administration of 105, 107,
and 108–9 live bacteria caused infection in roughly 40%, 50%,
and 95% percent of volunteers (Glynn et al., 1995). In the case
of Vibrio cholera, oral inoculation of healthy human volunteers
with 104 bacteria did not cause diarrhea, while infection with
106 live bacteria induced diarrhea in 27%and 88%of volunteers,
depending on the infecting strain (Cash et al., 1974). Interpreta-
tion of these studies is difficult, as patients likely differed in terms
of previous exposures and overall immune competence. Never-
theless, it is reasonable to speculate that differences in the
intestinal microbiota of these volunteers accounted for marked
differences in susceptibility to infection by these GI pathogens.
Indeed, extensive animal studies indicate that vulnerability to
infection by intestinal pathogens is markedly increased by prior
disruption of the intestinal microbiota.
In an effort to establish animal models of infection with Vibrio
cholera or S. enterica, guinea pigs and mice, respectively,
were treated with streptomycin and found to become highly
susceptible to infection (Bohnhoff and Miller, 1962; Freter,
1955). Vancomycin and streptomycin treatment rendered mice
highly susceptible to S. enterica colitis, while treatment withCell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc. 317
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metronidazole treatment of the 129S1/SvImJ mouse strain,
which had a distinct commensal microbiota, resulted in severe
S. enterica colitis. Analysis of the microbiota suggested a corre-
lation between the presence of bacteria belonging to the
Porphyromonadaceae family and resistance to S. enterica colitis
(Ferreira et al., 2011). Metronidazole treatment of mice has been
found to decrease the thickness of the colonic mucus layer,
resulting in increased susceptibility to C. rodentium infection
(Wlodarska et al., 2011).
Obligate anaerobic bacteria of the gut have been proposed
to provide colonization resistance against pathogenic organisms
such as Salmonella (Bohnhoff et al., 1964a, 1964b). Products
of obligate anaerobic metabolism, such as acetate and other
short-chain fatty acids, inhibit the growth of Salmonella.
Recent studies characterized the ability of different strains of
Bifidobacterium to provide protection against enterotoxigenic
E. coli infection. Strains of Bifidobacterium that produced
acetate enhanced resistance to E. coli infection by restricting
epithelial damage and toxin absorption (Fukuda et al., 2011).
Based on the recent genome sequencing, SFB are also pre-
dicted to have glycan transporters and enzymes to generate
acetate (Kuwahara et al., 2011; Prakash et al., 2011; Sczesnak
et al., 2011). This, along with enhanced Th17 induction in the
LP, may contribute to the ability of SFB to confer resistance
against infection with C. rodentium (Ivanov et al., 2009).
Host inflammatory responses to infection by intestinal patho-
gens, such as S. enterica or C. rodentium, alter the composition
of the microbiota, leading to a loss of bacterial membership
and expansion, in particular, of bacteria belonging to the Enter-
obacteriaceae family (Lupp et al., 2007; Stecher et al., 2007).
S. enterica-induced expansion of Enterobacteriaceae has
been correlated with the entry of neutrophils into the intestinal
lumen (Sekirov et al., 2010). Inflammation-induced alteration
of the microbiota enhances S. enterica persistence and expan-
sion in the intestinal lumen by mechanisms that remain incom-
pletely defined (Stecher et al., 2007). S. enterica, in contrast to
most commensal microbes, is capable of benefitting from
inflammatory responses by selective lipocalin-2 resistance
(Raffatellu et al., 2009) and the ability to utilize tetrathionate as
a terminal electron acceptor (Winter et al., 2010). Comparison
of mice colonized with a range of bacterial populations
demonstrated that colonization with bacteria belonging to the
Enterobacteriaceae family rendered mice more susceptible to
S. enterica infection (Stecher et al., 2010). This finding suggests
that Enterobacteriaceae either condition the gut to be more
receptive to other members of this family or the abundance
of Enterobacteriaceae reflects a more receptive intestinal
environment, perhaps reflecting a paucity of other, inhibitory
commensal bacteria. While reintroduction of complex microbial
populations eliminated S. enterica from the GI tract and was
independent of intestinal host IgA production, which members
of the microbiota perform this function remains unclear (Endt
et al., 2010). Speculation that obligate anaerobes contribute to
the protective function, as initially suggested by the work from
Bohnhoff nearly 50 years ago, remains enticing. Whether
commensal microbes enlist the host innate immune system to
eliminate S. enterica from the gut remains unclear and requires
further investigation.318 Cell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc.Clostridium difficile is a Gram-positive, spore-forming rod that
causes a spectrum of intestinal diseases extending from rela-
tively mild diarrhea to toxic megacolon (Kelly and LaMont,
2008; O’Connor et al., 2009). C. difficile-associated disease
(CDAD) generally occurs in hospitalized patients or individuals
residing in other long-term health care facilities and is almost
always associated with the administration of antibiotics. Since
2005, the incidence of CDAD has increased dramatically in
the United States (and other countries also), from less than
150,000 cases in 2000 to an estimated 500,000 cases in
2006, with approximately 15,000–20,000 deaths (Rupnik et al.,
2009). C. difficile causes disease in the colon by secreting two
toxins, referred to as toxin A and toxin B, which enter intestinal
epithelial cells and glucosylate Rho GTPases, disrupting the
cytoskeleton and destroying the integrity of the mucosal barrier.
C. difficile is acquired by the oral ingestion of spores from
a contaminated environment (Rupnik et al., 2009). Hospitals
are notorious for contamination with C. difficile spores, and
C. difficile spores are notoriously difficult to inactivate. The GI
tract of humans can be colonized with C. difficile. The rate of
C. difficile colonization in the general population is approximately
2%–3%, while colonization rates in hospitalized patients ranges
from10% to 25% (Bartlett andGerding, 2008; Simor et al., 2002).
Although specific strains of C. difficile are associated with more
severe disease, it remains unclear which host or microbial
factors determine recurrence and the extent or duration of
CDAD. A recent study investigating stool samples from patients
with and without C. difficile infection suggested that recurrent
infections occur in a setting of diminished microbial diversity
(Chang et al., 2008).
Recent studies demonstrate that antibiotic treatment of
C57BL/6 mice renders them susceptible to infection with
C. difficile, with mortality correlating with the inoculum of spores
(Chen et al., 2008; Lawley et al., 2009). Administration of five anti-
biotics to C57BL/6 mice obtained from Jackson Laboratory
followed by a single dose of clindamycin rendered mice highly
susceptible to C. difficile infection, with pathologic changes in
the cecum and colon that closely resembled changes seen
during human infection (Chen et al., 2008). Intestinal disease
and mortality vary markedly in antibiotic-treated mice, depend-
ing on the strain of C. difficile and also the host mouse strain.
Mice surviving C. difficile colitis developed long-term immunity,
although the mechanism of immune protection remains unde-
fined. Mice that did not receive antibiotics became colonized
upon inoculation withC. difficile and shed low numbers of spores
for several months after inoculation. Treatment of colonizedmice
with clindamycin markedly increased shedding of spores and
correlated with an antibiotic-induced decrease in microbial
diversity in fecal samples (Lawley et al., 2009). Although super-
shedder mice had high frequencies of C. difficile bacteria in
stool (roughly 5% of total bacteria), they did not develop overt
disease. However, histologic examination of the cecum and
colon revealed evidence of mild epithelial inflammation and
damage. MyD88-deficient mice were highly susceptible to
C. difficile infection and developed severe weight loss and diar-
rhea (Lawley et al., 2009). It remains unclear whether mortality
resulted directly from C. difficile infection or from intestinal
epithelial damage and dissemination of other intestinal bacteria.
Nod1-deficient mice had decreased neutrophil recruitment to
Figure 3. Factors Involved in Maintenance or Disruption of the
Mutualistic Balance of Host Functions and the Microbiota
The schematic depicts the homeostasis that exists between microbiota
(including both commensals and ‘‘pathobionts’’), components of host immu-
nity, and the host tissue (represented with blue arrows). This homeostasis can
be disturbed and dysbiosis introduced (represented by black arrows) by
extrinsic factors, including antibiotics, diet, environmental toxins, and acute
enteric pathogens, and intrinsic factors such as the host’s genetic makeup.
Understanding and manipulating these parameters to reset homeostasis
could be exploited as strategies to reverse the deleterious consequences of
infection with pathogens or antibiotic-induced dysbiosis.
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epithelium, leading to markedly increased mortality (Hasegawa
et al., 2011), suggesting that early neutrophil recruitment to
the colon during C. difficile infection creates a barrier that
prevents systemic dissemination of intestinal microbes. While
our understanding of immune defense against C. difficile is
only rudimentary, it is likely that experimental investigation of
the newly developed murine model of C. difficile colitis will
provide new insights and lead to new approaches to prevent
this infection.
Intestinal Domination by Commensal Bacteria
The ability of the normal intestinal microbiota to limit the integra-
tion of exogenously introduced, foreign bacteria into the existing
population is referred to as colonization resistance (van derWaaij
et al., 1971; Vollaard and Clasener, 1994). Colonization resis-
tance contributes to resistance against infection by intestinal
pathogens, which, as a rule, must grow in the intestinal lumen
in order to cause disease. Studies of colonization resistance
have principally focused on competition between microbes,
leading to a search for mechanisms by which one microbe
suppresses its competitors. However, recent advances in our
understanding of mucosal immune compartments have led
to the hypothesis that commensal microbes activate innate
immune mechanisms that suppress competing microbes,
adding a layer of complexity that is only beginning to be
investigated. This new perspective may provide insights into
some classic studies that quantified the expansion of some
intestinal microbes upon antibiotic administration. For example,
early studies demonstrated that antibiotic administration
enhanced intestinal colonization by Enterobacter cloacae and
K. pneumoniae, two members of the Enterobacteriaceae family,
while untreated mice rapidly eliminated these organisms from
the GI tract (Vollaard and Clasener, 1994). Studies in humans
also demonstrated that antibiotics that eliminated obligate
anaerobic bacteria increased the density of Enterobacteriaceae
and Enterococcaceae (Vollaard and Clasener, 1994).
The progressive development of antibiotic resistance in these
bacterial families and their ability to thrive in the GI tract when
colonization resistance is compromised has created a significant
and costly clinical problem. For example, VRE has, over the past
two decades, become a major cause of hospital-acquired
bacteremia (Kamboj et al., 2010). Clinical studies demonstrated
that antibiotics that kill anaerobic bacteria result in marked
increases in the density of VRE in human fecal samples (Donskey
et al., 2000). VRE, in both mice and humans, can overwhelmingly
colonize the intestinal lumen, at times representing 99% of the
bacterial flora (Ubeda et al., 2010). Although VRE, unlike
C. difficile, is not known to express virulence factors to enable
intestinal epithelial invasion or damage, overly dense coloniza-
tion of the gut is associated with VRE blood stream infection
(Ubeda et al., 2010). While the complex microbiota inhabiting
the intestine stimulates expression of antimicrobial factors,
such as RegIIIg, it is possible that innate immune defenses are
compromised when microbial diversity is lost and one microbial
species predominates. Further studies are required to investi-
gate the hypothesis that organisms such as VRE and various En-
terobacteriaceae become problematic because they do not
stimulate the host’s innate immune defenses.Strategies to Reverse Antibiotic-Induced Susceptibility
to Intestinal Infection and Restore Homeostasis
The intestinal microbiota enhance resistance to infection by
bacterial pathogens and rogue commensals by multiple mecha-
nisms. First, intestinal commensals, in particular obligate anaer-
obic bacteria, directly inhibit growth of aerobic bacteria such as
Enterococcaceae and Enterobacteriaceae. Second, intestinal
commensal bacteria stimulate the expression of antimicrobial
factors such as RegIIIg, thereby protecting the epithelial layer
from invasion by lumenal bacteria and also regulating the
balance of constituents of the microbial community. Third, stim-
ulation of both innate and adaptive immune responses by micro-
biota results in production of cytokines that strengthen the
epithelial barrier (e.g., IL-22) and in recruitment of phagocytes
that can rapidly clear any invasion resulting from the breach in
barrier functions. A fourth likely mechanism, largely conceptual
at this time, is host tolerance to commensal microbes. This
mechanism would not involve the immune system, but rather
the integrity of the host infrastructure, e.g., metabolic pathways
or cellular structures, allowing the host to tolerate high microbial
loads. Examples of host tolerance to microbes that could
become pathogenic abound in nature, but molecular mecha-
nisms have largely remained unexplored (Schneider and Ayres,
2008). Although the relative contributions of the different mech-
anisms noted above are currently unknown, they could poten-
tially be exploited in strategies to reverse the deleterious conse-
quences of infection with pathogens or dysbiosis, e.g., following
antibiotic-mediated depletion of the intestinal microbiota
(Figure 3). Which bacterial taxa mediate colonization resistance
remains unclear, but determining their identity may enhanceCell Host & Microbe 10, October 20, 2011 ª2011 Elsevier Inc. 319
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with or following antibiotic treatment in order to maintain resis-
tance against microbial pathogens. How intestinal bacteria
mediate colonization resistance also remains incompletely
defined, but determining the identity of bacterially produced
factors that inhibit the growth of pathogens will likely lead to
new approaches to restrict their growth and pathogenesis. Stim-
ulation of TLRs or other innate immune receptors to drive the
expression of host antimicrobial factors represents another
promising approach to enhance mucosal resistance during and
following antibiotic treatment. An additional option might be to
administer bacteria or their products that stimulate specific
T cell subsets (or ILCs) to induce production of protective
cytokines, such as IL-22. TLR and other signals could also be
bypassed by administering such cytokines to directly induce
antimicrobial protein expression by epithelial cells. Finally, a
growing understanding of the concept of host tolerance to intes-
tinal microbes may also reveal molecular processes that can be
manipulated to enhance the host infrastructure and confer
protection even in the setting of dysbiosis.
Future Perspectives
Although our understanding of the relationship of microbiota and
the immune system is rudimentary, recent studies suggest that,
by targeting this axis, it will be possible to apply preventive and
therapeutic approaches to multiple inflammatory and infectious
diseases. For example, insights into how individual microbes
or their specific products alter the proportions of effector to
Treg cells in the intestine could potentially be applied to thera-
pies for autoimmune disease or to preventing graft rejection.
Manipulation of the intestinal immune system could also provide
therapies for growing problems such as antibiotic-induced dys-
biosis and infections with antibiotic-resistant bacteria. A further
understanding of how different branches of the host immune
system interact in the face of concurrent microbial challenges
may also provide better defenses against viral infections: for
example, microbiota have been reported to influence the
outcome of airway infection with influenza virus, and the human
immunodeficiency virus replicates extensively in the LP, where it
preferentially depletes Th17 cells. The intersection of the micro-
biota, the host genetic makeup, and the host immune system
promises to provide exciting new therapeutic opportunities in
the near future.
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